AVAI BIO, INC. (AVAI) stock: key figures, P/E, revenue and dividend

Information Technology · United States

Price
0.07 USD
Market cap
10.84 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
62.15 %
Return on assets (ROA)
-305.49 %

AVAI BIO, INC. financials

Fiscal year20252026
Operating income-1.14 m USD-1.75 m USD
EBIT-1.14 m USD-1.75 m USD
Net income-1.14 m USD-1.75 m USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About AVAI BIO, INC.

Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. It also offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.